"Hospital Universitario Fundacion Jimenez Diaz"
Welcome,         Profile    Billing    Logout  
 3 Trials 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gómez, Manuel Dómine
NCT03739710 / 2018-001316-29: Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Non-small Cell Lung Cancer (NSCLC)

Checkmark Novel Regimens Versus Standard-of-Care in NSCLC: A Phase II, Randomized, Open-Label, Platform Trial Using a Master Protocol
Recruiting
2
341
Europe, Canada, US, RoW
Docetaxel, GSK3359609 (feladilimab), Ipilimumab, Niraparib, Dostarlimab, Cobolimab
GlaxoSmithKline
Neoplasms
03/25
03/25
NCT03866187: A Study to Evaluate the Reactogenicity, Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' HBV (Hepatitis B Virus) Viral Vector Vaccines and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection.

Recruiting
1
148
Europe, RoW
ChAd155-hIi-HBV low dose formulation, ChAd155-hIi-HBV high dose formulation, HBc-HBs/AS01B-4 low dose formulation, HBc-HBs/AS01B-4 high dose formulation, MVA-HBV low dose formulation, MVA-HBV high dose formulation, Placebo
GlaxoSmithKline
Hepatitis B, Chronic
01/25
01/25
NCT04009122: Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206

Recruiting
N/A
280
Europe
IGEN0206, Placebo
Igen BioLab SLU
Quality of Life of Patients, Non-small Cell Lung Cancer Metastatic
12/21
12/22

Download Options